Featured

It has been since many years that the concept when it comes to automation has gone on to push many into a panic. Though such automated technologies happen to have enormous potential, some are indeed worried that way too...

The requirement when it comes to caring for pharma’s in transit has never before been so high. With instability within the political spectrum reigning high and also affecting global trade routes as well as fragile economics, thereby causing the...

The European Medicines Agency- EMA and the Heads of Medicines Agencies- HMAs have gone on to publish a plan that helps to set out a collaborative as well as coordinated strategy so as to maximize the advantages of artificial...

The Worldwide Advanced Empty Capsule sector is anticipated to be worth US$ 905.6 million this year in 2023 and is expected to key in a CAGR of 7.4% in the next 10 years. It is well to be noted...

The introduction of gene therapies and therapeutic proteins has marked a revolutionary step in combating disease. However, these advanced treatments must navigate the challenging landscape of immunogenicity, where the body's defense system reacts to the introduced medication, potentially negating...

For emerging drug developers, the shift from lab to clinic is a transition that can lay the groundwork for success at many future milestones – from key early regulatory submissions to future partnerships and investment rounds. It’s an especially...

Across the healthcare industry, we are continually seeking ways to improve patient outcomes, advance medical knowledge and enhance the overall well-being of society. One critical aspect of this pursuit is ensuring clinical trials are diverse to represent the people...